BackAcrivon Therapeutics Overview

Acrivon Therapeutics Current Assets

Latest current assets for ACRV: $91M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$91.49M
↓ 33.90% YoYΔ $-46.92M vs prior year quarter

Peer trimmed avg / median

Loading

Acrivon Therapeutics Current Assets History

Loading

Acrivon Therapeutics vs. peers: Current Assets Comparison

Loading

Acrivon Therapeutics Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Acrivon Therapeutics (ACRV) FAQ

Acrivon Therapeutics posts a current assets of $91M as of June 2026. That compares with $140M in the prior-year period — down 33.9% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Acrivon Therapeutics's current assets was $140M. The latest reading is $91M — a 33.9% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Current Assets is one piece of Acrivon Therapeutics's financial statement story. At $91M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for ACRV's current assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Acrivon Therapeutics's other metric pages and overview cover the third.